As of 2025-07-07, the Relative Valuation of Dae Hwa Pharm Co Ltd (067080.KQ) is 2,762.45 KRW. This relative valuation is based on P/E multiples. With the latest stock price at 15,310.00 KRW, the upside of Dae Hwa Pharm Co Ltd based on Relative Valuation is -82.0%.
The range of the Relative Valuation is 1,089.13 - 4,413.62 KRW.
| Range | Selected | |
| Trailing P/E multiples | 11.6x - 19.5x | 16.0x |
| Forward P/E multiples | 12.9x - 15.8x | 14.4x |
| Fair Price | 1,089.13 - 4,413.62 | 2,762.45 |
| Upside | -92.9% - -71.2% | -82.0% |
| Date | P/E |
| 2025-06-25 | 156.56 |
| 2025-06-24 | 156.66 |
| 2025-06-23 | 153.16 |
| 2025-06-20 | 159.32 |
| 2025-06-19 | 162.29 |
| 2025-06-18 | 162.61 |
| 2025-06-17 | 167.17 |
| 2025-06-16 | 164.73 |
| 2025-06-13 | 164.09 |
| 2025-06-12 | 168.23 |
| 2025-06-11 | 170.57 |
| 2025-06-10 | 168.87 |
| 2025-06-09 | 169.50 |
| 2025-06-05 | 169.40 |
| 2025-06-04 | 171.95 |
| 2025-06-02 | 171.52 |
| 2025-05-30 | 173.96 |
| 2025-05-29 | 171.31 |
| 2025-05-28 | 170.57 |
| 2025-05-27 | 164.52 |
| 2025-05-26 | 159.42 |
| 2025-05-23 | 144.99 |
| 2025-05-22 | 151.78 |
| 2025-05-21 | 155.92 |
| 2025-05-20 | 151.67 |
| 2025-05-19 | 150.72 |
| 2025-05-16 | 155.07 |
| 2025-05-15 | 159.21 |
| 2025-05-14 | 160.80 |
| 2025-05-13 | 160.80 |
| 2025-05-12 | 155.28 |
| 2025-05-09 | 156.24 |
| 2025-05-08 | 163.45 |
| 2025-05-07 | 151.78 |
| 2025-05-02 | 159.53 |
| 2025-04-30 | 158.25 |
| 2025-04-29 | 160.59 |
| 2025-04-28 | 166.43 |
| 2025-04-25 | 174.71 |
| 2025-04-24 | 178.85 |
| 2025-04-23 | 180.44 |
| 2025-04-22 | 179.59 |
| 2025-04-21 | 175.34 |
| 2025-04-18 | 170.88 |
| 2025-04-17 | 176.51 |
| 2025-04-16 | 171.73 |
| 2025-04-15 | 180.22 |
| 2025-04-14 | 187.65 |
| 2025-04-11 | 144.35 |
| 2025-04-10 | 141.59 |